Monitor the stock for continued dilution pressure. The offering provides limited near-term relief; watch for potential further capital raises or partnership updates as the company seeks additional funding.
Price Chart
Executive Summary
Jupiter Neurosciences priced a registered direct offering of 7,142,858 shares at $0.28/share, raising ~$2.0M gross proceeds. The offering is dilutive (approx. 29% of market cap) for a clinical-stage biotech with a going concern qualification. Proceeds provide limited runway, and the company faces ongoing cash burn.
Key Facts
- Registered direct offering of 7,142,858 shares at $0.28/share for $2.0M gross proceeds.
- Placement agent D. Boral Capital receives 7% cash fee plus expense reimbursement up to $75,000.
- Closing expected on or about May 21, 2026, subject to customary conditions.
- Company has a going concern qualification and limited cash runway per prior filings.
- 30-day lock-up on further equity issuance (with exceptions).
Financial Impact
Gross proceeds of $2.0M; net proceeds ~$1.685M after placement agent fees and expenses.
Risk Factors
- Significant dilution to existing shareholders (approx. 29% based on pre-offering market cap).
- Company may require additional financing within the next 12 months given going concern qualification.
- Clinical-stage pipeline (JOTROL, ALA-002) carries development and regulatory risk.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-024748 |
| Exhibit: ex1-1.htm | 0001493152-26-024748 |
| Exhibit: ex5-1.htm | 0001493152-26-024748 |
| Exhibit: ex99-1.htm | 0001493152-26-024748 |
| Document: form8-k.htm | 0001493152-26-024748 |
| Document: 0001493152-26-024748-index-headers.html | 0001493152-26-024748 |
| Document: 0001493152-26-024748-index.html | 0001493152-26-024748 |
| Document: 0001493152-26-024748.txt | 0001493152-26-024748 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | SC 13G/A | $2.88 | awaiting T+5 | — | $2.86 (−0.69%) |
Sep 24, 2026 4w ago | S-3 | $2.67 $2.55 | ▲ +4.49% | ▲ +4.27% | $2.86 (−7.12%) |
Sep 22, 2026 4w ago | SC 13G | $2.98 $2.58 | ▼ −13.42% | ▼ −12.24% | $2.86 (−4.03%) |
Aug 28, 2026 8w ago | 8-K | $3.54 $3.08 | ▲ +12.99% | ▲ +12.85% | $2.86 (+19.21%) |
Aug 27, 2026 8w ago | 8-K | $4.89 $3.26 | ▲ +33.33% | ▲ +33.60% | $2.86 (+41.51%) |
Aug 24, 2026 9w ago | 8-K | $5.17 $3.35 | ▲ +35.20% | ▲ +34.66% | $2.86 (+44.68%) |
Aug 24, 2026 9w ago | 8-K | $5.66 $3.54 | ▲ +37.46% | ▲ +37.92% | $2.86 (+49.47%) |
Aug 24, 2026 9w ago | 424B5 | $5.66 $3.54 | ▲ +37.46% | ▲ +37.92% | $2.86 (+49.47%) |
Jul 27, 2026 13w ago | 8-K | $0.1135 $0.1000 | ▲ +11.89% | ▲ +14.41% | $2.86 (−2419.82%) |
Jul 21, 2026 14w ago | Press Release | $0.1697 $0.1097 | ▼ −35.36% | ▼ −34.36% | $2.86 (+1585.33%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers